[144] Stoke Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

STOK filed a Form 144 notice for the proposed sale of 42,461 shares of common stock through Morgan Stanley Smith Barney LLC, reflecting an aggregate market value of $1,053,882.02. The notice lists NASDAQ as the exchange with an approximate sale date of October 3, 2025.

The shares were acquired as restricted stock units on March 15, 2025. Shares outstanding were 54,797,418. Recent Rule 10b5‑1 activity by Edward Kaye over the prior three months included several sales, such as 45,996 shares on September 3, 2025 for $925,858.08 and 14,860 shares on September 2, 2025 for $299,259.60.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	42461	1053882.02	54797418	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2025	Restricted Stock Units	Issuer			42461	03/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	09/03/2025	45996	925858.08
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	09/02/2025	14860	299259.60
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	08/29/2025	1029	20580.00
EDWARD M KAYE 45 Wiggins Ave Bedford MA 01730	Common	08/18/2025	12126	221153.99

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does STOK’s Form 144 filing disclose?

A proposed sale of 42,461 common shares with an aggregate market value of $1,053,882.02.

When is the approximate sale date for the STOK shares?

The notice lists an approximate sale date of October 3, 2025.

On which exchange are the STOK shares planned to be sold?

The notice names NASDAQ as the exchange.

How were the shares to be sold acquired?

They were acquired as restricted stock units on March 15, 2025.

How many STOK shares are outstanding?

Shares outstanding were 54,797,418.

Who is the broker listed for the proposed sale?

The broker is Morgan Stanley Smith Barney LLC (Executive Financial Services).

What recent 10b5-1 sales related to STOK were disclosed?

Examples include 45,996 shares on September 3, 2025 for $925,858.08 and 14,860 shares on September 2, 2025 for $299,259.60.